Relation between Bioresorbable Scaffold Sizing Using QCA-Dmax and Long-term Clinical Outcomes in 1,232 Patients from 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).

@article{Katagiri2018RelationBB,
  title={Relation between Bioresorbable Scaffold Sizing Using QCA-Dmax and Long-term Clinical Outcomes in 1,232 Patients from 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).},
  author={Yuki Katagiri and Yoshinobu Onuma and Taku Asano and Ply Chichareon and Carlos Adolfo Collet and Yosuke Miyazaki and Jan J. Piek and Joanna J. Wykrzykowska and Alexandre S Abizaid and John A Ormiston and Bernard Chevalier and Patrick W. Serruys},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2018}
}
AIMS This study sought to investigate the long-term clinical outcomes related to scaffold sizing based on quantitative coronary angiography. METHODS AND RESULTS A total of 1,248 patients who received Absorb bioresorbable scaffolds in the ABSORB Cohort B, ABSOR EXTEND, ABSORB II trials were included in the analysis. The incidence of MACE (a composite of… CONTINUE READING